Griffin TW - Search Results

1

Phase I and preliminary phase II study of neocarzinostatin.

Griffin TW, Comis RL, Lokich JJ, Blum RH, Canellos GP. Griffin TW, et al. Cancer Treat Rep. 1978 Dec;62(12):2019-25. Cancer Treat Rep. 1978. PMID: 221112

2

Treatment of acute nonlymphocytic leukemia with neocarzinostatin.

Griffin TW, Lister TA, Rybak ME, Rosenthal DS, Canellos GP, Woodruff R, Oliver KT. Griffin TW, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1853-6. Cancer Treat Rep. 1979. PMID: 160835 Clinical Trial.

3

Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans.

Comis RL, Griffin TW, Raso V, Ginsberg SJ. Comis RL, et al. Among authors: griffin tw. Cancer Res. 1979 Mar;39(3):757-61. Cancer Res. 1979. PMID: 154969 No abstract available.

4

Neocarzinostatin: initial clinical and pharmacologic studies in the United States.

Comis RL, Griffin T, Raso V, Ginsberg SJ. Comis RL, et al. Recent Results Cancer Res. 1978;63:261-71. doi: 10.1007/978-3-642-81219-4_25. Recent Results Cancer Res. 1978. PMID: 151900 No abstract available.

5

High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer.

Hunter RE, Griffin TW, Stevens S, Roman LD, Bokhari F, Reale FR, Tak WK, Fitzgerald TJ, Dillon MB, Rose PG. Hunter RE, et al. Among authors: griffin tw. Cancer. 1991 Nov 1;68(9):1890-4. doi: 10.1002/1097-0142(19911101)68:9<1890::aid-cncr2820680907>3.0.co;2-t. Cancer. 1991. PMID: 1655227 Clinical Trial.

6

Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay.

Cobb WR, Bogden AE, Reich SD, Griffin TW, Kelton DE, LePage DJ. Cobb WR, et al. Among authors: griffin tw. Cancer Treat Rep. 1983 Feb;67(2):173-8. Cancer Treat Rep. 1983. PMID: 6825125 No abstract available.

7

Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy.

Griffin TW, Bogden AE, Reich SD, Antonelli D, Hunter RE, Ward A, Yu DT, Greene HL, Costanza ME. Griffin TW, et al. Cancer. 1983 Dec 15;52(12):2185-92. doi: 10.1002/1097-0142(19831215)52:12<2185::aid-cncr2820521202>3.0.co;2-p. Cancer. 1983. PMID: 6357424 Clinical Trial.

8

Treatment of advanced ovarian cancer with sequential combination chemotherapy.

Griffin TW, Hunter RA, Cederbaum AI, Tak WK, Ward AD, Schwartz JH, Halpin TF, Strauss GM, Meyer RN, Liepman MK, et al. Griffin TW, et al. Cancer. 1987 Nov 1;60(9):2150-5. doi: 10.1002/1097-0142(19871101)60:9<2150::aid-cncr2820600905>3.0.co;2-0. Cancer. 1987. PMID: 2830953

9

The cytarabine syndrome in an adult.

Shah SS, Rybak ME, Griffin TW. Shah SS, et al. Among authors: griffin tw. Cancer Treat Rep. 1983 Apr;67(4):405-6. Cancer Treat Rep. 1983. PMID: 6601987 No abstract available.

10

Phase I and pharmacokinetic study of the oral fluoropyrimidine capecitabine in combination with paclitaxel in patients with advanced solid malignancies.

Villalona-Calero MA, Weiss GR, Burris HA, Kraynak M, Rodrigues G, Drengler RL, Eckhardt SG, Reigner B, Moczygemba J, Burger HU, Griffin T, Von Hoff DD, Rowinsky EK. Villalona-Calero MA, et al. J Clin Oncol. 1999 Jun;17(6):1915-25. doi: 10.1200/JCO.1999.17.6.1915. J Clin Oncol. 1999. PMID: 10561233 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page